Physician profile
Matthew Teich
NPI 1649308123
$1,595.40
in general payments reported to CMS, 2019-2025
9 companies · $452 in 2025
The $452 reported for 2025 was more than what 89% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $116 · 2021: $63.87 · 2022: $245 · 2023: $206 · 2024: $275 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $475.56 | 2019-2025 | Invisalign, Itero Element 5d Plus |
| Geistlich Pharma, North America, INC. | $431.80 | 2024-2025 | Biomaterials, Geistlich Bio-Gide |
| Biohorizons Implant Systems INC. | $238.25 | 2022-2024 | Biohorizons |
| Zimmer Biomet Holdings, INC. | $180.58 | 2019-2020 | |
| Dentsply Sirona INC | $104.58 | 2021-2023 | Nupro, Ankylos |
| Dentsply Ih INC. | $64.82 | 2019 | |
| Straumann USA LLC | $62.58 | 2019-2022 | |
| Envista Holdings Corporation | $23.49 | 2025 | K3xf |
| Orapharma, A Division of Bausch Health US, LLC | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Teich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.